Background: While prolongation of QRS duration and QTc interval during acute myocardial
INTRODUCTION
Acute myocardial infarction (AMI) is a major cause of death and disability worldwide. As highly effective treatments are available, early and accurate detection of AMI is crucial [1] [2] [3] .
Clinical assessment, the 12-lead electrocardiogram (ECG) and cardiac troponin (cTn) form the cornerstones for the early diagnosis of AMI [1] .
The 12-lead ECG recording devices have been equipped with software more than two decades ago to automatically calculate both QRS duration and corrected QT interval (QTc). Animal studies investigating ECG changes after induction of an ischemic state found an acute prolongation of ventricular depolarization as reflected by QRS duration and of ventricular repolarization as indicated by QTc interval, with some suggesting a dose dependent effect between the amount of ischemia and the prolongation observed [4] [5] [6] . In humans, the induction of ischemia during exercise stress testing or balloon angioplasty resulted in prolongation of both QRS duration and QTc interval [7, 8] . QTc prolongation seemed to occur even earlier than conventional ECG markers of ischemia including ST deviation [8] . Despite this promising experimental data, the diagnostic value of QRS duration and QTc interval for the diagnosis of AMI has never been assessed in unselected patients presenting with symptoms suggestive of AMI.
Besides the need to rapidly rule-in or rule-out AMI, risk stratification is important in patients presenting with chest pain. Prolongation of QRS duration and QTc interval have been identified as markers of all-cause and cardiovascular mortality in the setting of AMI in the era of thrombolysis [9] [10] [11] . After the emergence of percutaneous coronary interventions as the preferred treatment of AMI, both markers were still found to predict mortality after AMI independently [12] [13] [14] . Due to the definitions of AMI applied in these studies, most patients suffered from extensive infarctions [9] [10] [11] [12] [13] [14] . With the introduction of more sensitive biomarkers, much smaller AMI's can be diagnosed nowadays [1, 15, 16] . Whether the prognostic value of the QRS duration and the QTc interval found earlier is still valid for contemporary AMI patients diagnosed with high-sensitive cardiac troponin (hs-cTn) assays is unknown.
This study therefore assessed the diagnostic and prognostic value of QRS duration and QTc interval in a large prospective cohort of patients presenting to the ED with symptoms suggestive of AMI and diagnoses adjudicated based on hs-cTn levels.
METHODS

Study design and population
Advantageous Predictors of Acute Coronary Syndrome Evaluation (APACE) is an ongoing prospective international multicenter study designed to advance the early diagnosis of AMI (ClinicalTrials.gov registry, number NCT00470587) [17] [18] [19] [20] .
Unselected patients presenting to the ED with symptoms suggestive of AMI (such as acute chest discomfort and angina pectoris) with an onset or peak within the last 12 h and an age > 18 years were recruited.
The study was carried out according to the principles of the Declaration of Helsinki and approved by the local ethics committees. Written informed consent was obtained from all patients.
The authors designed the study, gathered, and analysed the data according to the STARD guidelines for studies of diagnostic accuracy (see Supplemental Appendix for details), vouch for the data and analysis, wrote the paper, and decided to publish [21] .
Routine clinical assessment and hs-cTnT measurement
All patients underwent a clinical assessment that included medical history, physical examination, 12-lead ECG, pulse oximetry and standard blood test. Levels of high-sensitive cardiac Troponin T (hs-cTnT, Roche Diagnostics) were measured at presentation and serially thereafter as long as clinically indicated. For hs-cTnT, limit of blank and limit of detection have been determined to be 3 ng/L and 5 ng/L, an imprecision corresponding to 10% coefficient of variation was reported at 13 ng/l and the 99 th -percentile of a healthy reference population at 14 ng/L [22] . Timing and treatment of patients was left to the discretion of the attending physician.
Adjudication of final diagnoses
Two independent cardiologists reviewed all available medical records -patient history, physical examination, results of laboratory testing, radiologic testing, ECG, echocardiography, cardiac exercise stress test, lesion severity and morphology in coronary angiography -pertaining to patients from the time of ED presentation to 90-days follow up. In situations of disagreement about the diagnosis, cases were reviewed and adjudicated in conjunction with a third cardiologist.
Adjudication of the final diagnosis was performed centrally in a core lab (University Hospital Basel) and included two sets of serial cTn measurements: serial cTn measurements obtained as part of routine clinical care locally (different (h)s-cTn assays), and serial measurements of hs-cTnT from study blood draws performed centrally in a core laboratory in order to take advantage of the higher sensitivity and higher overall diagnostic accuracy offered by hs-cTnT.
AMI was defined and hs-cTn levels interpreted as recommended in current guidelines. 1 In brief, AMI was diagnosed when there was evidence of myocardial necrosis with a significant rise and/or fall in a clinical setting consistent with myocardial ischemia. Details on the adjudication of AMI are given in the online supplemental appendix.
ECG Recording, manual analysis and calculation of QRS duration and QTc interval
At presentation to the ED, a standard 10-second 12-lead resting ECG was recorded using a defined as recommended in current guidelines [1] .
QRS duration and QT interval were measured automatically using standard ECG software.
The QRS duration was measured from the beginning of the first detected Q-wave from all 12 averaged QRS complexes, to the end of the last S-wave from all 12 averaged QRS complexes. The QT interval was measured from the beginning of the first QRS taken from all 12 averaged leads to the end of the last T-wave taken from all 12 averaged leads. The QT interval was adjusted for mean heart rate to calculate the QTc interval using the Bazett formula [23] . Prolonged QRS interval was prospectively defined as QRS interval > 120 ms, 24 and prolonged QTc interval was prospectively defined as QTc interval > 440 ms [25] .
The digital ECG archive of the University Hospital Basel was further interrogated with regards to previous ECG's recorded within 90 days before the index admission. If available, those ECG's were used to calculate the difference in QRS duration and QTc interval.
Follow-up
After hospital discharge, patients were contacted after 3, 12 and 24 months by telephone or in written form. Information regarding death was furthermore obtained from the national registry on mortality, the hospital's diagnosis registry and the family physician records. including all significant predictors from univariate analysis.
Statistical analysis
All hypothesis testing was two-tailed and p-values < 0.05 were considered statistically significant. All statistical analyses were performed using IBM SPSS for Windows 23.0 (IBM SPSS Inc, Chicago, IL).
RESULTS
Enrolment and characteristics of patients
From April 2006 to August 2015, a total of 4323 unselected patients were enrolled. Patients with unknown diagnosis after adjudication and at least one elevated hs-cTnT level possibly indicating AMI were excluded (n = 99), as were patients with missing ECG at presentation (n = 90)
or ECGs with ventricular pacing (n = 92). This left 4042 patients eligible for analysis (Fig. 1 ).
Baseline characteristics of the 4042 patients with acute chest pain are shown in Table 1 . The adjudicated final diagnosis was AMI in 764 (19%) patients. Unstable angina was the diagnosis in 377 (9%), cardiac symptoms of origin other than CAD in 552 (14%), non-cardiac symptoms in 2185 (54%) and symptoms of unknown origin in 164 (4%).
Levels of QRS duration and QTc interval
QRS duration of more than 120 ms was recorded in 9% of patients, QTc interval of more than 440 ms in 32% of patients, respectively. Baseline characteristics of those groups are shown in Tables 1 and 2 . Patients with prolonged QRS duration or QTc interval were older, had more cardiovascular comorbidities and were more often taking cardiac medication. Fig. 2A ). This was observed in both patients with AMI and in patients with other diagnoses (p < 0.001 for both comparisons, Fig. 2B, C) . These findings were also unchanged if patients with ST-elevation myocardial infarction (STEMI) were excluded and only patients with non ST-elevation myocardial infarction (NSTEMI) were analyzed (data not shown).
Diagnostic value of QRS duration and QTc interval for the diagnosis of AMI
In univariate Cox proportional hazard analysis, a QRS duration > 120 ms predicted mortality with a HR of 2.95 (95% CI 2.23-3.90, p < 0.001). After adjusting for important clinical and electrocardiographic parameters, the QRS duration was no longer significant (Table 3) . Fig. 3A ). This was observed in both patients with AMI and in patients with other diagnoses (p < 0.001 for both comparisons, Fig. 3B, C) . These findings were also unchanged if patients with STEMI were excluded and only patients with NSTEMI's were analyzed (data not shown).
In univariate Cox proportional hazard analysis, a QTc interval > 440 ms predicted mortality with a HR of 2.94 (95% CI 2.32-3.71, p < 0.001). After multivariable adjustment as described above, the QTc interval remained an independent predictor of mortality (HR 1.40, 95% CI 1.07-1.83, p = 0.01; Table 3 ).
DISCUSSION
This study assessed the diagnostic and prognostic value of QRS duration and QTc interval in a large prospective international multicenter cohort of 4141 patients presenting with symptoms suggestive of AMI. The following major findings are thus reported.
First, QRS duration and QTc interval were significantly longer in patients with AMI compared to patients with other causes of chest pain. However, due to a large overlap, the diagnostic value of both parameters was only modest and insufficient for added value in clinical practice (AUC 0.57 and 0.60). Second, both a prolonged QRS duration and a prolonged QTc interval predicted an increased mortality during follow-up. This was observed both in the overall cohort as well as in important subgroups of patients with AMI and in patients with other causes of chest pain. Third, after multivariable adjustment, prolongation of the QTc interval remained an independent predictor of mortality, while a prolonged QRS duration was not.
These findings have clinical implications: Patients presenting with acute chest pain are frequently seen in the ED and account for up to 10% of all ED consultations [26] . Rapid diagnostic assessment and risk stratification in these patients is crucial medically, given that many have a remarkably increased cardiovascular risk, but also economically given the large amount of patients 26]. Hence, additional easily available markers assisting in the management of these patients are warranted.
Diagnostic value of QRS duration and QTc interval
Current guidelines concerning the interpretation of 12-lead ECGs regarding the diagnosis of myocardial ischemia recommend focusing on ST-segment and T-wave alterations [1] . However, the diagnostic value of the 12-lead ECG particularly in patients without ST-elevations is limited [17] .
In animal models, an association between myocardial ischemia and prolongation of QRS duration has been shown [4] [5] [6] . Additionally clinical studies investigating QRS duration after induction of ischemia during coronary angiography showed direct proportionality between ischemia and QRS prolongation [6, 7, 27] . With regards to QT prolongation during myocardial ischemia, animal data as well as clinical data obtained during coronary angiography indicate that prolongation of the QT interval occurs much earlier and much more frequent than ST-segment or T-wave changes in the course of myocardial ischemia [8] . Despite the established association between myocardial ischemia and prolongation of both, the QRS duration as well as the QT interval, the diagnostic value of these two markers for the diagnosis of AMI, according to available research, has not been prospectively studied in unselected patients with chest pain. The present data indicates that despite a statistically significant prolongation of QRS duration and QTc interval in patients with AMI, the diagnostic value is limited and insufficient for use in clinical practice. The major reason for the limited diagnostic value is that there are many other reasons that affect for QRS duration and the QTc interval, particularly the occurrence of bundle branch blocks that dilute the potential effects induced by myocardial ischemia. Of importance, the assessment of intra-individual changes in QRS duration and QT interval compared to a prior ECG did not increase the diagnostic value in this study.
Prognostic value of QRS duration and QTc interval
QRS prolongation and QT interval prolongation have been shown to predict mortality in patients who survived myocardial infarction [9] [10] [11] [12] [13] [14] . Early studies have been carried out in the thrombolytic era [9] [10] [11] . Others that addressed the question in the era of PCI techniques were still dependent on the elevation of non-specific markers like creatinine kinase and liver enzymes regarding the diagnosis of AMI, and many patients enrolled were STEMI's [12] [13] [14] . As a consequence, most of the AMI patients in those cohorts had large myocardial infarctions resulting in a substantial loss of myocardium.
The present data corroborates previous studies in a way that prognostic value of a prolonged QRS duration and QTc interval can be extended to patients with smaller AMIs and NSTEMIs as diagnosed nowadays with high-sensitive cardiac troponin assays. Furthermore, a similar predictive value was found in patients presenting with acute chest pain overall, as well as in the subgroups of AMI patients, NSTEMI patients but also patients with chest pain other than AMI. One previous study has assessed prolongation of the QTc interval in NSTEMI patients and concluded that QTc is also a risk factor for mortality in these patients [28] . However, the findings in that study were based on a very low event rate of 4 deaths.
Limitations of the study
Potential limitations of the present study merit consideration. First, the prognostic endpoint used in this study was all-cause mortality, but not sudden cardiac death. Classification of death in clinical practice can sometimes be difficult and unreliable [29] . In addition, despite the large number of patients, the event rate of sudden cardiac death would have been too limited to allow meaningful analysis. Second, serial ECG's in these patients were not recorded and it cannot therefore provide comment on the impact and significance of fluctuations in QRS duration and QTc interval in short time or during the first 24-48 h. Third, while information on cardiac medication including amiodarone was collected, no information was available on non-cardiac medications potentially prolonging the QTc interval.
CONCLUSIONS
QRS duration and QTc interval are significantly prolonged in patients with AMI diagnosed based on hs-cTn levels compared to patients with other causes of chest pain. However, due to a large overlap, the diagnostic value of both parameters was insufficient for added value in clinical practice. With regards to prognosis, a prolongation of the QRS duration > 120 ms and of the QTc interval > 440 ms predicts mortality during follow-up. After adjustment for age and important ECG and clinical parameters, the QTc interval but not QRS duration remains an independent predictor of mortality. Table 2 Baseline characteristics of the patients according to QRS duration and QTc interval. 
